Webinar Thu. July 25 at 9am PT/12pm ET/6pm CET w/ Dr. Christina Lockwood titled, "Current Perspectives on Pre-Analytical Variables that Impact Liquid Biopsy Test Sensitivity" If you're doing, or interested in doing #liquidbiopsy you'll want to attend. Register at: https://lnkd.in/gVGjrgrM Registrants receive a link to the live webinar and to the recorded webinar afterward. #SamplePrepMatters #cfDNA #cfRNA #CTCs #oncologyresearch
nRichDX’s Post
More Relevant Posts
-
#AnnalsofOncology: High accuracy of a blood ctDNA-based multimodal test to detect #ColorectalCancer. https://ow.ly/fFkk50QnIVs #ctDNA #LiquidBiopsy #AdvancedAdenoma
-
-
🌟 Prof Christophe Deroose dives deep into patient selection for PRRT at ENETS 2024, revealing criteria that maximise treatment efficacy for neuroendocrine tumours. From the NETTER2 trial insights to the potential of Alpha PRRT, discover the evolving landscape of this potent therapy. Discover these vital insights. 👇 For all ENETS 2024 videos, find the link in the comments! #MediMix #ENETS2024 #PRRT #NeuroendocrineTumours #OncologyInnovation
-
Explore our new special issue "Dose Optimization in Oncology"! 📚🔬 Covering crucial topics from classical PK/PD to advanced modeling, simulation methodologies, and #MIDD for rational #clinicaltrial design in #oncology. Congrats to our amazing editorial team: Stefanie Hennig, Sriram Krishnaswami, Rajat Desikan, & Priya Jayachandran, PharmD, MSE. #PSPJournal #ASCPTFamily Explore the issue here: https://lnkd.in/gYQ5Dkt7
-
-
What is Cardio-Oncology? And why is it important? Dr Steven Lipshultz shares his thoughts. 🔗: https://lnkd.in/g6WrudQG #cardioonc #cardiooncologia #cardiooncology
-
CIRSE Vice-President Prof. Philippe L Pereira gave this year's ECIO Honorary Lecture, titled "Interventional oncology in an evidence-based and value-based healthcare system." In this lecture, he encouraged IOs to continue to improve their individual clinical expertise, work to solidify evidence in IO, and always keep the benefit to the patient in mind. The full lecture is now available for on-demand viewing via the #ECIO2024 platform! ➡️ https://t.ly/Y7bG1 #InterventionalOncology #interventionalradiology
-
-
💫 #ONCOnews 💫 🌟 Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial 👉 The results suggest that [89Zr]Zr-girentuximab PET–CT has a favourable safety profile and is a highly accurate, non-invasive imaging modality for the detection and characterisation of clear-cell renal cell carcinoma, which has the potential to be practice changing. 🔗 https://buff.ly/47pElIX #OncEd #OncoAlert
-
-
🌟 Day 2 Highlights from ENETS 2024: Prof Alain Hendlisz unveils cutting-edge research in neuroendocrine tumour care. From the promising combination of lenvatinib and everolimus to innovative approaches targeting DLL3, the day was rich with insights that could redefine treatment strategies. Explore these pivotal studies and their potential impact on patient care. Discover these vital insights. 👇 For all ENETS 2024 videos, find the link in the comments! #MediMix #ENETS2024 #NeuroendocrineTumors #OncologyResearch
-
#SolidTumor trials require #Imaging professionals immersed in the scientific advances & regulatory changes that may impact your #ClinicalDevelopment program. Learn how the therapeutic, modality, and regulatory expertise of your #MedicalImaging provider can make or break your #Antitumor trial. https://lnkd.in/grneSdk2 #ChooseCalyx #ClinicalTrials #Oncology
-
Experienced sonographer specializing in pelvic and abdominal ultrasound * Clinical research professional with expertise in image acquisition guideline and protocol documentation * Certified fertility and postpartum doula
#SolidTumor trials require #Imaging professionals immersed in the scientific advances & regulatory changes that may impact your #ClinicalDevelopment program. Learn how the therapeutic, modality, and regulatory expertise of your #MedicalImaging provider can make or break your #Antitumor trial. https://lnkd.in/eqxDVUPi #ChooseCalyx #ClinicalTrials #Oncology
Imaging in Solid Tumor Trials: Many Changes Can Impact Success | Calyx
calyx.dsmn8.com
-
AVANTES IN THE FIELD 🦷 We're excited to highlight this research study that uses diffuse reflectance spectroscopy (DRS) to detect precancerous lesions in the oral mucosa early. The study utilized an Avantes #spectrometer, analyzing backscattering spectra to differentiate between healthy and unhealthy tissues. This innovative approach promises non-invasive, cost-effective, and reliable early detection of oral cancer, marking a significant advancement in medical diagnostics. We're proud to see our technology contribute to healthcare innovations! Link to full research paper 📄: https://ow.ly/MmHq50SR1qF #Spectroscopy #MedicalResearch #OralCancer #EarlyDetection #Innovation
-
